0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Microfluidics"

Following a topic allows Research and Markets to customize your experience and provide personalized recommendations.
From
EUR$2,000USDGBP
From
EUR$950USDGBP
From
EUR$950USDGBP
From
EUR$850USDGBP
EUR$236USDGBP
EUR$24USDGBP
Biochips - Technologies, Markets & Companies - Product Thumbnail Image

Biochips - Technologies, Markets & Companies

  • Report
  • November 2021
  • 270 Pages
  • Global
From
EUR$2,500USDGBP
Animal Biotechnology - Technologies, Markets and Companies - Product Thumbnail Image

Animal Biotechnology - Technologies, Markets and Companies

  • Report
  • November 2021
  • 365 Pages
  • Global
From
EUR$3,500USDGBP
From
EUR$2,655USDGBP
From
EUR$2,655USDGBP
EUR$297USDGBP
EUR$154USDGBP
BioMEMS Devices - Product Thumbnail Image

BioMEMS Devices

  • Book
  • November 2024
EUR$193USDGBP
Loading Indicator

The Microfluidics market within the Biotechnology sector is a rapidly growing field of research and development. It is focused on the manipulation of small volumes of fluids, typically in the range of nanoliters to microliters. This technology is used to create miniaturized systems for a variety of applications, such as drug delivery, diagnostics, and cell sorting. Microfluidics has the potential to revolutionize the way biotechnology is used in the medical, pharmaceutical, and industrial sectors. The technology is used to create devices that can be used to analyze and manipulate biological samples, such as cells, proteins, and DNA. It can also be used to create miniature reactors for chemical synthesis and to develop new materials. Microfluidics has the potential to reduce the cost and complexity of many biotechnological processes. Some of the leading companies in the Microfluidics market include Fluidigm, Bio-Rad Laboratories, Agilent Technologies, and Merck KGaA. These companies are developing a range of products and services to meet the needs of the biotechnology industry. Show Less Read more